Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;162(2):359-367.
doi: 10.1007/s00705-016-3078-2. Epub 2016 Oct 18.

Characterization of a recombinant Newcastle disease virus expressing the glycoprotein of bovine ephemeral fever virus

Affiliations

Characterization of a recombinant Newcastle disease virus expressing the glycoprotein of bovine ephemeral fever virus

Minmin Zhang et al. Arch Virol. 2017 Feb.

Abstract

Bovine ephemeral fever (BEF) is caused by the arthropod-borne bovine ephemeral fever virus (BEFV), which is a member of the family Rhabdoviridae and the genus Ephemerovirus. BEFV causes an acute febrile infection in cattle and water buffalo. In this study, a recombinant Newcastle disease virus (NDV) expressing the glycoprotein (G) of BEFV (rL-BEFV-G) was constructed, and its biological characteristics in vitro and in vivo, pathogenicity, and immune response in mice and cattle were evaluated. BEFV G enabled NDV to spread from cell to cell. rL-BEFV-G remained nonvirulent in poultry and mice compared with vector LaSota virus. rL-BEFV-G triggered a high titer of neutralizing antibodies against BEFV in mice and cattle. These results suggest that rL-BEFV-G might be a suitable candidate vaccine against BEF.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig. 1
Fig. 1
Construction and identification of rL-BEFV-G. (A) Schematic representation of the rLaSota genome and BEFV G inserted between the P and M genes. (B) Western blot demonstrating the expression of BEFV G. BHK-21 cells were infected with rLaSota or rL-BEFV-G at an MOI of 1. After 24 h, cells were collected and lysed, and proteins in the cell lysate were separated by SDS-PAGE and immunoblotted with mouse anti-NDV antibodies or BEFV G polyclonal antibody. (C) Immunofluorescence analysis of BEFV G protein expression. BHK-21 cells were infected with rLaSota or rL-BEFV-G at an MOI of 0.01. After 24 h, the cells were fixed and then stained with chicken anti-NDV antibody or BEFV G polyclonal antibody, followed by incubation with FITC-conjugated goat anti-mouse antibody or TRITC-conjugated rabbit anti-chicken antibody
Fig. 2
Fig. 2
Cell-to-cell spread of rL-BEFV-G and NDV vector in BHK-21 cells. (A) Monolayers of BHK-21 cells were infected with either rLaSoTa or rL-BEFV-G at an MOI of 0.05. After five washes 1 h postinfection, the infected cells were incubated at 37 °C. The infected cells were examined at the indicated times post-infection using IFA with chicken serum against NDV. (B) Assay for inhibition of intercellular spread of recombinant virus in BHK-21 cells. Monolayers of BHK-21 cells were infected with either rL or rL-BEFV-G at an MOI of 0.05. After five washes 1 h postinfection, the cells were incubated with culture medium containing 100-fold-diluted mouse serum against NDV, mouse serum against BEFV, or naïve mouse serum. Infected cells were examined 72 h postinfection using IFA with chicken serum against NDV
Fig. 3
Fig. 3
Biological characteristics of rL-BEFV-G in poultry. (A) Kinetics of rL-BEFV-G replication in embryonated eggs. Ten-day-old embryonated eggs were infected with rLa or rL-BEFV-G at 105 TCID50. Allantoic fluid of six eggs from each group was harvested at 24, 48, 72 and 96 h postinoculation, and virus titers were determined in EID50 units in 10-day-old embryonated eggs. (B) Kinetics of rL-BEFV-G replication in MDBK cells. Monolayers of MDBK cells were infected with either egg-propagated rLaSota or rL-BEFV-G at an MOI of 0.01. After five washes 1 h postinfection, the cells were incubated with 100-fold-diluted mouse serum against NDV for 30 min to neutralize the residual viruses in the supernatants. After replacement of the medium with fresh medium, the infected cells were incubated at 37 °C in the absence (B) or presence (C) of TPCK trypsin (1 μg/ml). The culture supernatants were collected at different times, and their virus was titrated in MDBK cells with 1 μg of TPCK trypsin per ml. Significant differences between rLa and rL-BEFV-G were observed using Student’s t-test. *, P <0.05; **, P < 0.01. (D) Pathogenicity assay in SPF eggs and chickens. MDT, ICPI and IVPI were determined according to the recommended OIE method
Fig. 4
Fig. 4
Changes in body weight in mice inoculated with rL-BEFV-G. Mice were inoculated intramuscularly (A) or intracerebrally (B) with 107 TCID50 of rL-BEFV-G on day 0. Mice were observed and weighed daily from day 0 to 14. All mice survived for the duration of the experiment. Body weight changes for each group are shown as ratios relative to the body weight at day 0, which was set as 100 %
Fig. 5
Fig. 5
Serum neutralization analysis in mice. Serum samples were collected at different times after vaccination, and SN antibody titers for BEFV (A) and NDV (B) were measured. Statistically significant differences were determined using Student’s t-test. *, P < 0.05

Similar articles

Cited by

References

    1. Alexander D (1997) Newcastle disease and other avian paramyxovirus infections. In: Diseases of poultry, vol 50014. Iowa State University Press, Ames, pp 541–569
    1. Bevan L. Ephemeral fever or three day sickness of cattle. Vet J. 1912;68:458–461.
    1. Buijs PR, Verhagen JH, van Eijck CH, van den Hoogen BG. Oncolytic viruses: From bench to bedside with a focus on safety. Hum Vaccines immunother. 2015;11:1573–1584. doi: 10.1080/21645515.2015.1037058. - DOI - PMC - PubMed
    1. Bukreyev A, Skiadopoulos MH, Murphy BR, Collins PL. Nonsegmented negative-strand viruses as vaccine vectors. J Virol. 2006;80:10293–10306. doi: 10.1128/JVI.00919-06. - DOI - PMC - PubMed
    1. Bukreyev A, Collins PL. Newcastle disease virus as a vaccine vector for humans. Curr Opinion Mol Ther. 2008;10:46–55. - PubMed

MeSH terms

LinkOut - more resources